Mechanisms of neuronal death in Down’s syndrome

  • Zs. Nagy
Conference paper


There is growing evidence that neuronal death in Down’s syndrome is due to apoptotic mechanisms. The phenomena, however, that trigger and regulate programmed cell death in the Down’s syndrome-related neurodegeneration are still much debated.

In vitro evidence has suggested that the main factor responsible for neuronal death in this condition is the accumulation of β-amyloid, due to the overexpression of its precursor protein. Another hypothesis argues for the importance of reactive oxygen species in neuronal death. However, the in vivo findings do not entirely support either theories.

We propose that neuronal apoptosis, as well as the formation of Alzheimer-type pathology, in Down’s syndrome is due to an aberrant re-entry of neurones into the cell division cycle. Due to the simultaneous over expression of conflicting cell cycle regulatory signals, the mitogenic amyloid precursor and the differentiation factor S100, the cell cycle is abandoned. Subsequently the cell cycle arrest may lead to either the formation of Alzheimer-related pathology or to apoptotic cell death.


Neuronal Death Cell Division Cycle Paired Helical Filament Neurobiol Aging Paired Helical Filament 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322–1326PubMedCrossRefGoogle Scholar
  2. Altmann AE, Halliday JL, Giles GG (1998) Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer 78: 1244–1249PubMedCrossRefGoogle Scholar
  3. Alvarez J, Moreno RD, Inestrosa NC (1995) Mitosis of Schwann cells and demyelination are induced by the amyloid precursor protein and other protease inhibitors in the rat sciatic nerve. Eur J Neurosci 7: 152–159PubMedCrossRefGoogle Scholar
  4. Araujo DM, Cotman CW (1992) Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer’s disease. Brain Res 569:141–145PubMedCrossRefGoogle Scholar
  5. Armstrong RA (1996) Correlations between the morphology of diffuse and primitive beta-amyloid (A beta) deposits and the frequency of associated cells in Down’s syndrome. Neuropathol Appl Neurobiol 22: 527–530PubMedCrossRefGoogle Scholar
  6. Au WW, Wilkinson GS, Tyring SK, Legator MS, el Zein R, Hallberg L, Heo MY (1996) Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect 3: 579–584Google Scholar
  7. Bar Peled O, Korkotian E, Segal M, Groner Y (1996) Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons. Proc Natl Acad Sci USA 93: 8530–8535Google Scholar
  8. Barkats M, Bertholet JY, Venault P, Ceballos Picot I, Nicole A, Phillips J, Moutier R, Roubertoux P, Sinet PM, Cohen Salmon C (1993) Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene. Neurosci Lett 160: 24–28Google Scholar
  9. Birecree E, Whetsell WO, Jr, Stoscheck C, King LE, Jr, Nanney LB (1988) Immunoreac-tive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer’s disease. J Neuropathol Exp Neurol 47: 549–560PubMedCrossRefGoogle Scholar
  10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol Berl 82: 239–259PubMedCrossRefGoogle Scholar
  11. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779PubMedCrossRefGoogle Scholar
  12. Chiarugi V, Magnelli L, Cinelli M, Basi G (1994) Apoptosis and the cell cycle. Cell Mol Biol Res 40: 603–612PubMedGoogle Scholar
  13. Cotman CW (1998) Apoptosis decision cascades and neuronal degeneration in Alzheimer’s disease. Neurobiol Aging 19: S29–S32PubMedCrossRefGoogle Scholar
  14. de la Monte SM, Sohn YK, Ganju N, Wands JR (1998) P53-and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 78: 401–411PubMedGoogle Scholar
  15. Desjardins P, Ledoux S (1998) The role of apoptosis in neurodegenerative diseases. Metab Brain Dis 13: 79–96PubMedCrossRefGoogle Scholar
  16. Dieckmann KP, Rube C, Henke RP (1997) Association of Down’s syndrome and testicular cancer. J Urol 157: 1701–1704PubMedCrossRefGoogle Scholar
  17. Ferrer I, Gullotta F (1990) Down’s syndrome and Alzheimer’s disease: dendritic spine counts in the hippocampus. Acta Neuropathol Berl 79: 680–685PubMedCrossRefGoogle Scholar
  18. Grana X, Reddy EP (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211–219PubMedGoogle Scholar
  19. Hayn M, Kremser K, Singewald N, Cairns N, Nemethova M, Lubec B, Lubec G (1996) Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down’s syndrome and Alzheimer’s disease. Life Sci 59: 537–544PubMedCrossRefGoogle Scholar
  20. Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH (1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down’s syndrome. Quantitative regional analysis and comparison with Alzheimer’s disease. Arch Neurol 52: 379–391PubMedCrossRefGoogle Scholar
  21. Hyman BT (1992) Down syndrome and Alzheimer disease. Prog Clin Biol Res 379: 123–142PubMedGoogle Scholar
  22. Hyman BT, West HL, Rebeck GW, Lai F, Mann DM (1995) Neuropathological changes in Down’s syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch Neurol 52: 373–378PubMedCrossRefGoogle Scholar
  23. Imahori K, Uchida T (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer’s disease. J Biochem Tokyo 121: 179–188PubMedGoogle Scholar
  24. Lew J, Qi Z, Huang QQ, Paudel H, Matsuura I, Matsushita M, Zhu X, Wang JH (1995a) Structure, function, and regulation of neuronal Cdc2-like protein kinase. Neurobiol Aging 16: 263–268PubMedCrossRefGoogle Scholar
  25. Lew J, Wang JH (1995b) Neuronal cdc2-like kinase. Trends Biochem Sci 20: 33–37PubMedCrossRefGoogle Scholar
  26. Lovestone S, Reynolds CH (1997) The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78: 309–324PubMedCrossRefGoogle Scholar
  27. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3–15PubMedGoogle Scholar
  28. Mann DM, Yates PO (1986a) Neurotransmitter deficits in Alzheimer’s disease and in other dementing disorders. Hum Neurobiol 5: 147–158PubMedGoogle Scholar
  29. Mann DM, Yates PO, Marcyniuk B, Ravindra CR (1986b) The topography of plaques and tangles in Down’s syndrome patients of different ages. Neuropathol Appl Neurobiol 12: 447–457PubMedCrossRefGoogle Scholar
  30. Mann DM, Yates PO, Marcyniuk B, Ravindra CR (1987) Loss of neurones from cortical and subcortical areas in Down’s syndrome patients at middle age. Quantitative comparisons with younger Down’s patients and patients with Alzheimer’s disease. J Neurol Sci 80: 79–89PubMedCrossRefGoogle Scholar
  31. Mann DMA (1997) Neuropathological changes of Alzheimer’s disease in persons with Down’s syndrome. In: Esiri MM, Morris JH (eds) The neuropathology of dementia. Cambridge University Press, Cambridge, pp 122–136Google Scholar
  32. Masliah E, Mallory M, DeTeresa R, Alford M, Hansen L (1993a) Differing patterns of aberrant neuronal sprouting in Alzheimer’s disease with and without Lewy bodies. Brain Res 617: 258–266PubMedCrossRefGoogle Scholar
  33. Masliah E, Miller A, Terry RD (1993b) The synaptic organization of the neocortex in Alzheimer’s disease. Med Hypotheses 41: 334–340PubMedCrossRefGoogle Scholar
  34. Mattiace LA, Kress Y, Davies P, Ksiezak Reding H, Yen SH, Dickson DW (1991) Ubiquitin-immunoreactive dystrophic neuntes in Down’s syndrome brains. J Neuropathol Exp Neurol 50: 547–559Google Scholar
  35. Mattson MP (1997) Cellular actions fo beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77: 1081–1132PubMedGoogle Scholar
  36. Meikrantz W, Schlegel R (1995) Apoptosis and the cell cycle. J Cell Biochem 58:160–174PubMedCrossRefGoogle Scholar
  37. Nagy Zs, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD (1995) Relative roles of plaques and tangles in the dementia of Alzheimer’s disease: correlations using three sets of neuropathological criteria. Dementia 6: 21–31PubMedGoogle Scholar
  38. Nagy Zs, Esiri MM (1997a) Apoptosis-related protein expression in the hippocampus in Alzheimer’s disease. Neurobiol Aging 18: 565–571PubMedCrossRefGoogle Scholar
  39. Nagy Zs, Esiri MM, Cato AM, Smith AD (1997b) Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol Berl 94: 6–15PubMedCrossRefGoogle Scholar
  40. Nagy Zs, Esiri MM, Smith AD (1997c) Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions. Acta Neuropathol Berl 93: 294–300PubMedCrossRefGoogle Scholar
  41. Nagy Zs, Esiri MM, Smith AD (1998) The cell division cycle and the pathophysiology of Alzheimer’s disease. Neuroscience 84: 731–739Google Scholar
  42. Nagy Zs, Esiri MM, LeGris M, Matthews PM (1999) Mitochondrial enzyme expression in the hippocamppus in relation to Alzheimer-type pathology. Acta Neuropathol Berl 97: 346–354PubMedCrossRefGoogle Scholar
  43. Pines J (1994a) The cell cycle kinases. Semin Cancer Biol 5: 305–313PubMedGoogle Scholar
  44. Pines J (1994b) Protein kinases and cell cycle control. Semin Cell Biol 5: 399–408PubMedCrossRefGoogle Scholar
  45. Pines J (1995) Cyclins, CDKs and cancer. Semin Cancer Biol 6: 63–72PubMedCrossRefGoogle Scholar
  46. Prinz M, Prinz B, Schulz E (1997) The growth of non-pyramidal neurons in the primary motor cortex of man: a Golgi study. Histol Histopathol 12: 895–900PubMedGoogle Scholar
  47. Satge D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ (1997) An excess of testicular germ cell tumors in Down’s syndrome: three case reports and a review of the literature. Cancer 80: 929–935PubMedCrossRefGoogle Scholar
  48. Sawa A, Oyama F, Cairns NJ, Amano N, Matsushita M (1997) Aberrant expression of bcl-2 gene family in Down’s syndrome brains. Brain Res Mol Brain Res 48: 53–59PubMedCrossRefGoogle Scholar
  49. Smith TW, Lippa CF (1995) Ki-67 Immunoreactivity in Alzheimer’s disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54: 297–303PubMedCrossRefGoogle Scholar
  50. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1445–1449PubMedCrossRefGoogle Scholar
  51. Suzuki T, Ando K, Isohara T, Oishi M, Lim GS, Satoh Y, Wasco W, Tanzi RE, Nairn AC, Greengard P, Gandy SE, Kirino Y (1997) Phosphorylation of Alzheimer beta-amyloid precursor-like proteins. Biochemistry 36: 4643–4649PubMedCrossRefGoogle Scholar
  52. Sylvester PE (1984) Amnion’s horn or hippocampal sclerosis without epilepsy in mental handicap. Br J Psychiatry 144: 538–541PubMedCrossRefGoogle Scholar
  53. Takashima S, Iida K, Mito T, Arima M (1994) Dendritic and histochemical development and ageing in patients with Down’s syndrome. J Intellect Disabil Res 38: 265–273PubMedCrossRefGoogle Scholar
  54. Trojanowski JQ, Lee VM (1995) Phosphorylation of paired helical filament tau in Alzheimer’s disease neurofibrillary lesions: focusing on phosphatases. Faseb J 9: 1570–1576PubMedGoogle Scholar
  55. Vincent I, Rosado M, Davies P (1996) Mitotic mechanisms in Alzheimer’s disease? J Cell Biol 132: 413–425PubMedCrossRefGoogle Scholar
  56. Vincent I, Jicha G, Rosado M, Dickson DW (1997) Aberrant expression of mitotic cdc2/ cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain. J Neurosci 17:3588–3598PubMedGoogle Scholar
  57. Vincent I, Ding XL, Zheng JH, Zhang SH (1998a) Mitotic kinases: initiators and mediators of neurodegeneration? Neurobiol Aging [Suppl] 4SGoogle Scholar
  58. Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P (1998b) Mitotic phosphoepitopes precede paired helical filaments in Alzheimer’s disease. Neurobiol Aging 19: 287–296PubMedCrossRefGoogle Scholar
  59. Whitaker Azmitia PM, Wingate M, Borella A, Gerlai R, Roder J, Azmitia EC (1997) Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer’s disease and Down’s syndrome. Brain Res 776: 51–60Google Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • Zs. Nagy
    • 1
    • 2
  1. 1.OPTIMA, Departments of Neuropathology and PharmacologyUniversity of OxfordOxfordUK
  2. 2.OPTIMARadcliffe Infirmary NHS TrustOxfordUK

Personalised recommendations